Literature DB >> 19486036

Imatinib: a designer drug, another cutaneous complication.

E Dickens1, F Lewis, N Bienz.   

Abstract

A 55-year-old man with a history of mild psoriasis was started on imatinib for chronic myeloid leukaemia. He developed new nail dystrophy after treatment with an exacerbation of his psoriasis. Although not a contraindication for this drug, it should be remembered that psoriasis may worsen with imatinib.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19486036     DOI: 10.1111/j.1365-2230.2009.03250.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  3 in total

Review 1.  Tyrosine kinases in inflammatory dermatologic disease.

Authors:  Ricardo T Paniagua; David F Fiorentino; Lorinda Chung; William H Robinson
Journal:  J Am Acad Dermatol       Date:  2010-06-26       Impact factor: 11.527

2.  Pharmacological control of receptor of advanced glycation end-products and its biological effects in psoriasis.

Authors:  A V Mezentsev; S A Bruskin; A G Soboleva; V V Sobolev; E S Piruzian
Journal:  Int J Biomed Sci       Date:  2013-09

3.  Imatinib-induced psoriasis.

Authors:  Figen Atalay; Ebru Kızılkılıç; R Simin Ada
Journal:  Turk J Haematol       Date:  2013-06-05       Impact factor: 1.831

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.